Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 430 citing Fischl: The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly.... (0.10 sec) 

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of …


WA O'Brien, PM Hartigan, D Martin, J … - The New England …, 1996 - nejm.highwire.org
Results Among the 129 patients in the immediate-treatment group, 34 had disease that progressed
to AIDS, as compared with 57 of the 141 patients in the deferred-treatment group (P = 0.03). Progression
to AIDS correlated strongly with base-line CD4+ lymphocyte counts (P = 0.001) and ...
Cited by 595 - Related articles - BL Direct - All 5 versions

A trial comparing nucleoside monotherapy with combination therapy in HIV- …


SM Hammer, DA Katzenstein, MD Hughes, H … - The New England …, 1996 - nejm.highwire.org
Results Progression to the primary end point was more frequent with zidovudine alone (32
percent) than with zidovudine plus didanosine (18 percent; relative hazard ratio, 0.50;
P<0.001), zidovudine plus zalcitabine (20 percent; relative hazard ratio, 0.54; P<0.001), ...
Cited by 573 - Related articles - BL Direct - All 6 versions

Antiretroviral therapy for HIV infection in 1996. Recommendations of an …


CC Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM … - Jama, 1996 - Am Med Assoc
OBJECTIVE--To provide clinical recommendations for antiretroviral therapy for human immunodeficiency
virus (HIV) disease with currently (mid 1996) available drugs. When to start therapy, what to start
with, when to change, and what to change to were addressed. PARTICIPANTS--A 13- ...
Cited by 543 - Related articles - BL Direct - All 5 versions

A health status questionnaire using 30 items from the Medical Outcomes Study


AW Wu, HR Rubin, WC Mathews, JE Ware Jr, LT Brysk, … - Medical Care, 1991 - jstor.org
Preliminary Validation in Persons With Early HIV Infection ... ALBERT W. WU, MD, MPH,* HAYA
R. RUBIN, MD, PHD,t WILLIAM C. MATHEWS, MD, MSPHt JOHN E. WARE, JR., PHD,? LUCY
T. BRYSK, MA,T WILLIAM D. HARDY, MD, ... STEPHEN A. SPECTOR, MD,# AND ...
Cited by 397 - Related articles - All 3 versions

CD4⁺ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human …


DS Stein, JA Korvick, SH Vermund - The Journal of infectious diseases, 1992 - jstor.org
CD^ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human ... Daniel S.
Stein, Joyce A. Korvick, and Sten H. Vermund Medical and Epidemiology Branches, Clinical
Research Program, Division of AIDS, National Institutes of Allergy and Infectious ...
Cited by 289 - Related articles - All 3 versions

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter …


TR O'brien, WA Blattner, D Waters, E Eyster, MW … - Jama, 1996 - Am Med Assoc
OBJECTIVE--To determine if the long-term incidence of the acquired immunodeficiency syndrome
(AIDS) is related to human immunodeficiency virus type 1 (HIV-1) RNA levels measured early
in HIV-1 infection. DESIGN--Epidemiologic cohort study. SETTING--Five hemophilia ...
Cited by 284 - Related articles - BL Direct - All 3 versions

Racial differences in the use of drug therapy for HIV disease in an urban …


RD Moore, D Stanton, R Gopalan, RE … - New England Journal of …, 1994 - content.nejm.org
Results Among the 838 patients enrolled, 656 (79 percent) were blacks, 167 (20 percent) were
non-Hispanic whites, and 15 (2 percent) were Asian or Hispanic or were not racially
classified. There were no racial differences in the stage of HIV disease at the time of ...
Cited by 284 - Related articles - BL Direct - All 5 versions

The impact of the syncytium-inducing phenotype of human immunodeficiency virus …


DD Richman, SA Bozzette - The Journal of infectious diseases, 1994 - jstor.org
Figure 3. Adjusted survival curves for end points. Curves were ad- justed to survival probability
of asymptomatic patient receiving zi- dovudine who had 341 CD4 cells/ mm'. Compared with
data in figure 2, differences between NSI and SI for time to <200 and to <50 CD4 cells ...
Cited by 281 - Related articles - BL Direct - All 3 versions

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV- …

- annals.org
JM Schapiro, MA Winters, F Stewart, B Efron … - Annals of internal …, 1996 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To evaluate the efficacy
and safety of high-dose therapy with the human immunodeficiency virus (HIV) protease ...
Cited by 267 - Related articles - BL Direct - All 3 versions

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human …

- nih.gov [PDF] 
SM Daluge, SS Good, MB Faletto, WH Miller, … - Antimicrobial agents …, 1997 - aac.highwire.org
Page 1. A NTIMICROBIAL A GENTS AND C HEMOTHERAPY , 0066-4804/97/$04.00 0
May 1997, p. 1082–1093 Vol. 41, No. 5 Copyright © 1997, American Society for Microbiology
1592U89, a Novel Carbocyclic Nucleoside Analog with Potent, ...
Cited by 236 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google